Authors: George Rajna
Researchers in Germany have started collecting data with a 60 million euro ($71 million) machine designed to help determine the mass of the universe's lightest particle.  By analyzing data collected over eight years ago, scientists at the U.S. Department of Energy's (DOE) Argonne National Laboratory and Fermi National Accelerator Laboratory have made a potentially groundbreaking discovery.  Now, in a new result unveiled today at the Neutrino 2018 conference in Heidelberg, Germany, the collaboration has announced its first results using antineutrinos, and has seen strong evidence of muon antineutrinos oscillating into electron antineutrinos over long distances, a phenomenon that has never been unambiguously observed.  The Precision Reactor Oscillation and Spectrum Experiment (PROSPECT) has completed the installation of a novel antineutrino detector that will probe the possible existence of a new form of matter.  The MINERvA collaboration analyzed data from the interactions of an antineutrino— the antimatter partner of a neutrino—with a nucleus.  The inclusion of short-range interactions in models of neutrinoless double-beta decay could impact the interpretation of experimental searches for the elusive decay.  The occasional decay of neutrons into dark matter particles could solve a long-standing discrepancy in neutron decay experiments.  The U.S. Department of Energy has approved funding and start of construction for the SuperCDMS SNOLAB experiment, which will begin operations in the early 2020s to hunt for hypothetical dark matter particles called weakly interacting massive particles, or WIMPs.  Thanks to low-noise superconducting quantum amplifiers invented at the University of California, Berkeley, physicists are now embarking on the most sensitive search yet for axions, one of today's top candidates for dark matter. 
Comments: 68 Pages.
[v1] 2018-06-11 07:17:13
Unique-IP document downloads: 36 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.